Retatrutide is investigated as a triple receptor agonist , interacting with GLP-1 receptors, GIP receptors, and glucagon receptors
Other medications may involve cardiovascular risks (phentermine), neurological or cognitive side effects (Qsymia), or mood-related concerns (Contrave)
The Rybelsus Vision Loss Lawsuit is an active lawsuit See If You Qualify Rybelsus, an oral semaglutide prescribed to treat type 2 diabetes but commonly used for weight loss, has been linked to severe vision side effects, including blurry vision, vision loss, and blindness
Limon, J
Protocol Designed by Sherry, Pharm.D
The decline is often irregular, with good days and bad days rather than a smooth improvement curve